Skip to main content
Psychedelic State(s) of America
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices

Policy Tracker

Full Bill Tracker

Every tracked proposal: pending, failed, superseded, stalled and enacted — across psychedelics, cannabis, kratom and 7-OH.

United States

Bills tracked for this country and its states or regions.

Laws & timeline

272 of 272 tracked bills · newest recorded action first

  • New Jersey · Kratom
    Pending
    S2271

    CJ’s Law (2026–2027)

    1. IntroducedJan 13, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Transferred to Senate Law and Public Safety.

    Companion manufacture/distribution restriction proposal. Not limited to 7-OH.

    Bill source (opens in a new tab)
  • Michigan · Kratom
    Pending
    SB1181

    Kratom Consumer Protection Act (2025–2026)

    1. IntroducedSep 22, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred to Senate Regulatory Affairs.

    Current-session kratom product regulation proposal; not enacted.

    Bill source (opens in a new tab)
  • New Jersey · 7-OH
    Pending
    A5359

    7-hydroxymitragynine scheduling (2026–2027)

    1. IntroducedSep 10, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred to Assembly Judiciary.

    7-OH-specific Schedule I proposal, not an enacted whole-leaf ban.

    Bill source (opens in a new tab)
  • Delaware · Kratom
    Enacted
    HS1 for HB332

    Kratom Consumer Protection Act — enacted substitute (2026)

    1. IntroducedJun 11, 2026 (done)
    2. PassedDate TBC (done)
    3. SignedSep 8, 2026 (done)
    4. Law in effectSep 8, 2026 (done)

    · Signed; effective the same day.

    Volume 85 Chapter 478, replaces HB332; signed and effective 8 September 2026.

    Bill source (opens in a new tab)
  • United States · Kratom
    Pending
    H.R. 10272

    End Gas Station Heroin Act (119th Congress (2025–2026))

    1. IntroducedSep 3, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred to House Energy and Commerce and Judiciary.

    Would schedule 7-OH and mitragynine pseudoindoxyl. Natural kratom exemption requires at most 1 mg/g solids or 1 mg/mL liquids and 1 part per 100 parts mitragynine by mass. Synthesized, concentrated, enriched or manufactured material is not exempt. Separate commercial-enforcement possession protections are not a general exemption from scheduling.

    Bill source (opens in a new tab)
  • California · Psychedelics
    Pending
    SB1224

    The California Emerging Therapies Research Partnership Act. (2026 Session)

    1. IntroducedFeb 19, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · August 13 hearing: Held in committee and under submission.

    Bill source (opens in a new tab)
  • Massachusetts · Kratom
    Superseded by a new draft
    S.1609

    An Act concerning the regulation of Kratom (2025–2026)

    1. IntroducedDate TBC (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Accompanied new draft S3198.

    Replaced by S3198 on 10 August 2026; not a separate pending proposal. Successor history still needs confirmation.

    Bill source (opens in a new tab)
  • United States · Kratom
    Pending
    S. 5383

    End Gas Station Heroin Act (119th Congress (2025–2026))

    1. IntroducedAug 8, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Read twice; referred to Senate Judiciary.

    Would schedule 7-OH and mitragynine pseudoindoxyl. Natural kratom exemption requires at most 1 mg/g solids or 1 mg/mL liquids and 1 part per 100 parts mitragynine by mass. Synthesized, concentrated, enriched or manufactured material is not exempt. Not a blanket whole-leaf ban.

    Bill source (opens in a new tab)
  • Louisiana · Psychedelics
    Enacted
    SB43

    Provides relative to psychedelic-assisted therapy (2026 Regular Session)

    Session: March 9, 2026 – June 1, 2026

    1. IntroducedMar 9, 2026 (done)
    2. PassedDate TBC (done)
    3. SignedDate TBC (done)
    4. Law in effectAug 1, 2026 (done)

    · Effective date 8/1/2026.

    Became Act 956 without the Governor's signature on June 23, 2026.

    Bill source (opens in a new tab)
  • Massachusetts · Psychedelics
    Pending
    H4200

    An Act authorizing a pilot for the use of psychedelics in licensed treatment facilities (194th General Court (2025–2026))

    Session: January 1, 2025 – January 5, 2027

    1. IntroducedMar 27, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred

    Still pending as of Oct 21, 2026: reported favourably and sent to House Ways and Means on July 23, 2026.

    Bill source (opens in a new tab)
  • United States · Kratom
    Pending
    H.R. 9913

    Safe Sips Act of 2026 (119th Congress (2025–2026))

    1. IntroducedJul 23, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred to House Energy and Commerce and Ways and Means.

    Color-coded labeling proposal for intoxicating drinks, including kratom-related substances and 7-OH. Not a kratom scheduling or prohibition bill.

    Bill source (opens in a new tab)
  • Massachusetts · Psychedelics
    Pending
    H2203

    Establishing a pilot program for access to regulated psilocybin (2026 Session)

    1. IntroducedFeb 27, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred

    Bill source (opens in a new tab)
  • New Hampshire · Psychedelics
    Enacted
    HB1772

    Relative to prescribing ibogaine for investigational use only and adopting the physician associate licensure compact. (2026 Regular Session)

    Session: January 7, 2026 – June 4, 2026

    1. IntroducedJan 7, 2026 (done)
    2. PassedJun 4, 2026 (done)
    3. SignedJul 15, 2026 (done)
    4. Law in effectSep 13, 2026 (done)

    · Signed into Law

    Bill source (opens in a new tab)
  • United States · Psychedelics
    Pending
    HB9559

    IBOGAINE Act (119th Congress)

    Session: January 3, 2025 – January 3, 2027

    1. IntroducedJun 30, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred

    Still pending as of Oct 21, 2026: referred to the Subcommittee on Health on July 17, 2026.

    Bill source (opens in a new tab)
  • Massachusetts · Psychedelics
    Pending
    H4986

    Relative to therapeutic psilocybin treatment centers (2026 Session)

    1. IntroducedJan 28, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Reporting date extended to Thursday, December 31, 2026

    Bill source (opens in a new tab)
  • Arizona · Psychedelics
    Enacted
    SB1188

    approved medications; scheduling; prescription authority (2026 Regular Session)

    Session: January 12, 2026 – June 13, 2026

    1. IntroducedDate TBC (done)
    2. PassedJun 10, 2026 (done)
    3. SignedJun 22, 2026 (done)
    4. Law in effectNext step (current)

    · Passed

    Bill source (opens in a new tab)
  • California · Kratom
    Stalled; passage deadline elapsed
    AB 1088

    Public health: kratom (2025–2026)

    1. IntroducedFeb 20, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Hearing canceled at author’s request.

    Official page retains committee label but no passage before regular-session deadline verified. Excluded from confidently pending count; no invented death date.

    Bill source (opens in a new tab)
  • Arizona · Psychedelics
    Pending
    SB1752

    Mescaline; possession; sale; commercial use (2026 Session)

    1. IntroducedFeb 5, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Assigned to House RULES Committee

    Bill source (opens in a new tab)
  • Delaware · Kratom
    Superseded by a new draft
    HB 332

    Kratom Consumer Protection Act (2026)

    1. IntroducedMar 26, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Replaced by HS1 for HB332.

    Original superseded; HS1 for HB332 became Chapter 478. Do not treat original bill text as enacted.

    Bill source (opens in a new tab)
  • Michigan · Kratom
    Pending
    HB4969

    Kratom product regulation (2025–2026)

    1. IntroducedSep 17, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Re-referred to House Regulatory Reform.

    Would regulate manufacture, distribution and sale of kratom products; not enacted.

    Bill source (opens in a new tab)
  • Michigan · Psychedelics
    Pending
    HB6020

    Health: research; participation in ibogaine clinical trials; provide for (2025–2026 Regular Session)

    Session: January 8, 2025 – December 31, 2026

    1. IntroducedMay 21, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Committee Report

    Committee recommendation concurred in on June 9, 2026; still pending (low confidence — check).

    Bill source (opens in a new tab)
  • New York · 7-OH
    Pending
    S8925

    7-OH product restrictions (2025–2026)

    1. IntroducedJan 16, 2026 (done)
    2. PassedJun 5, 2026 (done)
    3. SignedNext step (current)
    4. Law in effect— (upcoming)

    · Passed Assembly and returned to Senate.

    Passed both chambers in retrieved history; no governor signature confirmed. Targets 7-OH above 2% of total alkaloids or 1 mg per serving, not a blanket whole-leaf ban.

    Bill source (opens in a new tab)
  • Colorado · Psychedelics
    Enacted
    HB1325

    Natural Medicine (2026 Regular Session)

    Session: January 14, 2026 – May 13, 2026

    1. IntroducedMar 6, 2026 (done)
    2. PassedMay 13, 2026 (done)
    3. SignedJun 4, 2026 (done)
    4. Law in effectNext step (current)

    · Passed

    Bill source (opens in a new tab)
  • Connecticut · Psychedelics
    Enacted
    SB00191

    An Act Concerning the Psychedelic-Assisted Therapy Pilot Program (2026 February Session)

    Session: February 4, 2026 – May 6, 2026

    1. IntroducedFeb 11, 2026 (done)
    2. PassedMay 6, 2026 (done)
    3. SignedJun 4, 2026 (done)
    4. Law in effectJul 1, 2026 (done)

    · Passed

    Bill source (opens in a new tab)
  • Tennessee · Psychedelics
    Enacted
    HB2075

    AN ACT to amend Tennessee Code Annotated, Title 9; Title 33; Title 53; Title 63 and Title 68, relative to clinical trials. (2026 Session)

    1. IntroducedJan 23, 2026 (done)
    2. PassedDate TBC (done)
    3. SignedMay 27, 2026 (done)
    4. Law in effectNext step (current)

    · Signed into Law

    Bill source (opens in a new tab)
  • Tennessee · Psychedelics
    Enacted
    SB2149

    Relative to clinical trials (114th General Assembly (2025-2026))

    Session: January 14, 2025 – April 23, 2026

    1. IntroducedDate TBC (done)
    2. PassedApr 23, 2026 (done)
    3. SignedMay 22, 2026 (done)
    4. Law in effectMay 22, 2026 (done)

    · Assigned Public Chapter 1119

    Bill source (opens in a new tab)
  • Illinois · Psychedelics
    Pending
    SB2772

    Psilocybin Advisory Board (104th General Assembly (2025–2026))

    Session: January 8, 2025 – January 13, 2027

    1. IntroducedDate TBC (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred

    Still pending as of Oct 21, 2026: re-referred to House Rules Committee on May 15, 2026.

    Bill source (opens in a new tab)
  • California · Psychedelics
    Pending
    AB2489

    Controlled substances: research. (2026 Session)

    1. IntroducedFeb 20, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · In committee: Held under submission.

    Bill source (opens in a new tab)
  • Georgia · Psychedelics
    Enacted
    HB717

    Medical Practice Act; regulation of the administration of psychedelic-assisted treatment and therapy; provide (2025–2026 Regular Session)

    Session: January 13, 2025 – April 2, 2026

    1. IntroducedDate TBC (done)
    2. PassedMar 27, 2026 (done)
    3. SignedMay 12, 2026 (done)
    4. Law in effectJul 1, 2026 (done)

    · Signed into Law

    Bill source (opens in a new tab)
  • Oklahoma · Psychedelics
    Enacted
    HB3834

    Oklahoma Breakthrough Therapy Act (2026 Regular Session)

    Session: February 2, 2026 – May 15, 2026

    1. IntroducedJan 15, 2026 (done)
    2. PassedMay 6, 2026 (done)
    3. SignedMay 12, 2026 (done)
    4. Law in effectNext step (current)

    · Passed

    Bill source (opens in a new tab)
  • Georgia · Psychedelics
    Enacted
    HB382

    Controlled substances; Schedule I; psilocybin; revise a provision (2026 Session)

    1. IntroducedFeb 11, 2025 (done)
    2. PassedApr 10, 2026 (done)
    3. SignedMay 11, 2026 (done)
    4. Law in effectNext step (current)

    · Signed into Law

    Bill source (opens in a new tab)
  • New York · Psychedelics
    Pending
    A02142

    Allows the growth, cultivation, and adult use of psilocybin for the treatment of certain health conditions (2025-2026 Legislative Session)

    Session: January 8, 2025 – December 31, 2026

    1. IntroducedJan 15, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · print number 2142a

    Amended and recommitted to Health; still pending, latest action date unconfirmed (low confidence — check).

    Bill source (opens in a new tab)
  • New York · Psychedelics
    Pending
    S05303

    Allows the growth, cultivation, and adult use of psilocybin for the treatment of certain health conditions (2025-2026 Legislative Session)

    Session: January 8, 2025 – December 31, 2026

    1. IntroducedFeb 20, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · PRINT NUMBER 5303A

    Amended and recommitted to Health; still pending, latest action date unconfirmed (low confidence — check).

    Bill source (opens in a new tab)
  • Missouri · Psychedelics
    Pending
    HB1717

    Modifies provisions relating to alternative therapies and treatments, including psilocybin (2026 Session)

    1. IntroducedJan 7, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Committee Report

    Bill source (opens in a new tab)
  • Missouri · Psychedelics
    Pending
    HB2817

    Creates provisions relating to ibogaine treatment (2026 Session)

    1. IntroducedJan 7, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Placed Back on Formal Perfection Calendar (H)

    Bill source (opens in a new tab)
  • Missouri · Psychedelics
    Did not pass; died when the session ended
    SB1767

    Modifies provisions relating to alternative therapies and treatments, including psilocybin (2026 Session)

    1. IntroducedFeb 26, 2026 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • New Hampshire · Psychedelics
    Pending
    HB1809

    Authorizing the medical use of psilocybin through a program established in the department of health and human services. (2026 Session)

    1. IntroducedDec 18, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Inexpedient to Legislate, Motion Adopted, Voice Vote === BILL KILLED ===; 05/07/2026; Senate Journal 11

    Bill source (opens in a new tab)
  • North Carolina · Psychedelics
    Pending
    S1018

    The HEAL Act. (2025-2026 Session)

    Session: January 8, 2025 – December 18, 2026

    1. IntroducedApr 30, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred

    Still pending as of Oct 21, 2026: re-referred to Appropriations/Base Budget on May 5, 2026.

    Bill source (opens in a new tab)
  • Iowa · Psychedelics
    Pending
    HF978

    A bill for an act relating to the production and administration of psilocybin, and providing penalties. (Formerly HF 620.) (2026 Session)

    1. IntroducedMar 27, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Amendment S-5248 filed. S.J. 960.

    Bill source (opens in a new tab)
  • Hawaii · Psychedelics
    Pending
    SB3199

    Relating To Mental Health. (2026 Session)

    1. IntroducedJan 28, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Conference committee meeting to reconvene on 05-01-26 3:15PM; Conference Room 329.

    Bill source (opens in a new tab)
  • New York · Psychedelics
    Did not pass; died when the session ended
    S01817

    Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction. (2026 Session)

    1. IntroducedJan 14, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Committee Report

    Bill source (opens in a new tab)
  • Maryland · Psychedelics
    Enacted
    HB427

    Task Force on Responsible Use of Natural Psychedelic Substances - Extension and Membership (2026 Regular Session)

    Session: January 14, 2026 – April 13, 2026

    1. IntroducedJan 22, 2026 (done)
    2. PassedApr 10, 2026 (done)
    3. SignedApr 28, 2026 (done)
    4. Law in effectJul 1, 2026 (done)

    · Signed into Law

    Bill source (opens in a new tab)
  • Maryland · Psychedelics
    Enacted
    SB336

    Task Force on Responsible Use of Natural Psychedelic Substances - Extension and Membership (2026 Session)

    1. IntroducedJan 23, 2026 (done)
    2. PassedApr 3, 2026 (done)
    3. SignedApr 28, 2026 (done)
    4. Law in effectNext step (current)

    · Signed into Law

    Bill source (opens in a new tab)
  • Iowa · Kratom
    Current status not confirmed
    HF 2133

    Designating kratom as a Schedule I controlled substance (2026)

    1. IntroducedJan 21, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Amendment S-5215 filed.

    Passed House 17 March 2026, 69–26. No enactment shown; final session-end disposition unconfirmed. Excluded from current pending count.

    Bill source (opens in a new tab)
  • Minnesota · Psychedelics
    Did not pass; died when the session ended
    HF2906

    Psilocybin therapeutic use program established; protections for registered patients, designated cultivators, registered facilitators, and health care practitioners established; rulemaking authorized; civil actions authorized; fees established; advisory committee established; criminal penalties provided; and money appropriated. (2026 Session)

    1. IntroducedMar 27, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Author added Rymer

    Bill source (opens in a new tab)
  • Colorado · Psychedelics
    Enacted
    SB031

    Use of Prescription Product with Controlled Substance (2026 Session)

    1. IntroducedJan 22, 2026 (done)
    2. PassedApr 6, 2026 (done)
    3. SignedDate TBC (done)
    4. Law in effectNext step (current)

    · Passed

    Bill source (opens in a new tab)
  • Minnesota · Psychedelics
    Pending
    SF3971

    Psilocybin therapeutic use program establishment (2026 Session)

    1. IntroducedFeb 26, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Author added Seeberger

    Bill source (opens in a new tab)
  • Missouri · Psychedelics
    Did not pass; died when the session ended
    SB1682

    Modifies provisions relating to alternative therapies and treatments, including psilocybin (2026 Session)

    1. IntroducedFeb 19, 2026 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • Delaware · Kratom
    Superseded by a new draft
    SB 262

    Uniform Controlled Substances Act amendments (2026)

    1. IntroducedMar 18, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Replaced by SS1 for SB262.

    Original superseded by SS1 for SB262. Successor committee history does not establish current October pendency; no enactment verified.

    Bill source (opens in a new tab)
  • Kentucky · Psychedelics
    Enacted
    SB77

    An Act relating to ibogaine research in the Commonwealth (2026 Regular Session)

    Session: January 6, 2026 – April 15, 2026

    1. IntroducedJan 13, 2026 (done)
    2. PassedDate TBC (done)
    3. VetoedApr 13, 2026 (failed)
    4. SignedApr 14, 2026 (done)
    5. Law in effectNext step (current)

    · Referred

    Vetoed 13 Apr 2026; veto overridden 14 Apr 2026 (Senate 31–6, House 77–18); Acts Chapter 158.

    Bill source (opens in a new tab)
  • Oregon · Psychedelics
    Enacted
    HB4040

    Relating to health care; and declaring an emergency. (2026 Session)

    1. IntroducedFeb 2, 2026 (done)
    2. PassedMar 5, 2026 (done)
    3. SignedApr 13, 2026 (done)
    4. Law in effectNext step (current)

    · Signed into Law

    Bill source (opens in a new tab)
  • Minnesota · Psychedelics
    Pending
    HF4577

    Psilocybin therapeutic use program established; protections for registered patients, registered suppliers, registered facilitators, and health care practitioners established; civil actions authorized; advisory committee established; and money appropriated. (2026 Session)

    1. IntroducedMar 23, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Motion to recall and re-refer, motion prevailed Veterans and Military Affairs Division

    Bill source (opens in a new tab)
  • Rhode Island · Psychedelics
    Pending
    H7756

    Amends current law on controlled substances to permit psilocybin to be cultivated within a person's residence for personal use and contingent on the US FDA's program, mandate that RI department of health establish rules regulations. (2026 Session)

    1. IntroducedFeb 12, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Withdrawn at sponsor's request

    Bill source (opens in a new tab)
  • Virginia · Psychedelics
    Enacted
    HB1347

    Board of Pharmacy; regulation of psilocybin. (2026 Regular Session)

    Session: January 14, 2026 – March 14, 2026

    1. IntroducedDate TBC (done)
    2. PassedDate TBC (done)
    3. SignedDate TBC (done)
    4. Law in effectNext step (current)

    · Signed into Law

    Bill source (opens in a new tab)
  • Virginia · Psychedelics
    Enacted
    SB379

    Psilocybin; Board of Pharmacy to reschedule upon federal scheduling changes. (2026 Session)

    1. IntroducedJan 13, 2026 (done)
    2. PassedFeb 26, 2026 (done)
    3. SignedApr 6, 2026 (done)
    4. Law in effectNext step (current)

    · Signed into Law

    Bill source (opens in a new tab)
  • Hawaii · Psychedelics
    Pending
    SB1042

    Relating To Mental Health. (2026 Session)

    1. IntroducedJan 17, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Received notice of the discharge of all House Conferees (Hse. Com. No. 457).

    Bill source (opens in a new tab)
  • Massachusetts · Psychedelics
    Did not pass; died when the session ended
    H4050

    To amend the General Laws, in relation to promoting the health and well-being of the residents of the Commonwealth of Massachusetts by establishing a comprehensive framework supporting public health and safety through regulated adult use, support services, and cultivation of psilocybin-containing fungi; and providing for taxation and appropriation thereof (2026 Session)

    1. IntroducedApr 22, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Accompanied a study order, see H5318

    Bill source (opens in a new tab)
  • Missouri · Psychedelics
    Did not pass; died when the session ended
    SB1581

    Establishes the "Veterans Mental Health Innovation Act" relating to ibogaine treatment (2026 Session)

    1. IntroducedJan 20, 2026 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Voted Do Pass S Veterans and Military Affairs Committee

    Bill source (opens in a new tab)
  • West Virginia · Psychedelics
    Vetoed
    HB4626

    Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine (2026 Session)

    1. IntroducedJan 21, 2026 (done)
    2. PassedMar 12, 2026 (done)
    3. VetoedMar 14, 2026 (failed)
    4. SignedDid not happen (skipped)
    5. Law in effectDid not happen (skipped)

    · Vetoed by Governor 4/1/2026 - House Journal

    Bill source (opens in a new tab)
  • Illinois · Psychedelics
    Pending
    HB1143

    Illinois CURE Act (an act concerning health) (104th General Assembly (2025–2026))

    Session: January 8, 2025 – January 13, 2027

    1. IntroducedJan 9, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred

    Still pending as of Oct 21, 2026: re-referred to House Rules Committee on March 27, 2026.

    Bill source (opens in a new tab)
  • Illinois · Psychedelics
    Pending
    HB2992

    HOPE PILOT PROGRAM (2026 Session)

    1. IntroducedFeb 6, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred

    Bill source (opens in a new tab)
  • Illinois · Psychedelics
    Pending
    SB2184

    USE AND RESEARCH-ENTHEOGENS (2026 Session)

    1. IntroducedFeb 7, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred

    Bill source (opens in a new tab)
  • West Virginia · Psychedelics
    Enacted
    SB906

    Permitting lawful prescription of crystalline polymorph psilocybin under FDA recommendations (2026 Regular Session)

    Session: January 14, 2026 – March 14, 2026

    1. IntroducedFeb 10, 2026 (done)
    2. PassedMar 14, 2026 (done)
    3. SignedMar 27, 2026 (done)
    4. Law in effectJun 12, 2026 (done)

    · Approved by Governor 3/27/2026 - Senate Journal

    Bill source (opens in a new tab)
  • Massachusetts · Psychedelics
    Pending
    H1624

    Establishing a task force to study equitable access to psilocybin and other entheogenic plants (2026 Session)

    1. IntroducedFeb 27, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Accompanied a study order, see H5281 (under House Rule 27)

    Bill source (opens in a new tab)
  • Massachusetts · Psychedelics
    Pending
    H1726

    Relative to criminal disposition of limited psilocybin possession offenses (2026 Session)

    1. IntroducedFeb 27, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Accompanied a study order, see H5281 (under House Rule 27)

    Bill source (opens in a new tab)
  • Massachusetts · Psychedelics
    Pending
    H1858

    Relative to removing criminal penalties for limited psilocybin possession (2026 Session)

    1. IntroducedFeb 27, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Accompanied a study order, see H5281 (under House Rule 27)

    Bill source (opens in a new tab)
  • Mississippi · Psychedelics
    Enacted
    HB314

    Ibogaine; authorize SDH to select a consortium to conduct a drug development clinical trial with, to secure FDA's approval of. (2026 Session)

    1. IntroducedJan 8, 2026 (done)
    2. PassedMar 18, 2026 (done)
    3. SignedDate TBC (done)
    4. Law in effectNext step (current)

    · Passed

    Bill source (opens in a new tab)
  • Georgia · Psychedelics
    Did not pass; died when the session ended
    SB631

    "Veterans Mental Health Innovations Act"; enact (2026 Session)

    1. IntroducedMar 23, 2026 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • Utah · Psychedelics
    Enacted
    SB0083

    Controlled Substance Scheduling Amendments (2026 General Session)

    Session: January 20, 2026 – March 6, 2026

    1. IntroducedDate TBC (done)
    2. PassedDate TBC (done)
    3. SignedDate TBC (done)
    4. Law in effectNext step (current)

    · Passed

    Bill source (opens in a new tab)
  • Pennsylvania · Kratom
    Pending
    SB 899

    Kratom product regulation (2025–2026)

    1. IntroducedJun 30, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Laid on table under Senate Rule 9.

    Tabled; requires revival to progress. Not enacted and not conclusively dead.

    Bill source (opens in a new tab)
  • Hawaii · Psychedelics
    Pending
    SCR171

    Urging The Convening Of A Mental Health Emerging Therapies Task Force To Prepare The State For The Integration Of Breakthrough Therapies And To Explore Opportunities To Expand Clinical Trials, Research Partnerships, And Treatment Capacity In The State. (2026 Session)

    1. IntroducedMar 16, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred

    Bill source (opens in a new tab)
  • Hawaii · Psychedelics
    Pending
    SR162

    Urging The Convening Of A Mental Health Emerging Therapies Task Force To Prepare The State For The Integration Of Breakthrough Therapies And To Explore Opportunities To Expand Clinical Trials, Research Partnerships, And Treatment Capacity In The State. (2026 Session)

    1. IntroducedMar 16, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred

    Bill source (opens in a new tab)
  • United States · 7-OH
    Pending
    H.R. 8000

    END 7-OH Act (119th Congress (2025–2026))

    1. IntroducedMar 19, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred to House Energy and Commerce and Judiciary.

    Would schedule synthetic 7-OH; excludes 7-OH naturally contained in the kratom plant. Not a whole-leaf ban or enacted law.

    Bill source (opens in a new tab)
  • Utah · Psychedelics
    Enacted
    HB0390

    Veterans PTSD Clinical Research Amendments (2026 Session)

    1. IntroducedJan 27, 2026 (done)
    2. PassedMar 11, 2026 (done)
    3. SignedDate TBC (done)
    4. Law in effectNext step (current)

    · Passed

    Bill source (opens in a new tab)
  • Minnesota · Psychedelics
    Pending
    SF4485

    Psilocybin therapeutic use program establishment (2026 Session)

    1. IntroducedMar 17, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Introduced

    Bill source (opens in a new tab)
  • Idaho · Psychedelics
    Pending
    H0899

    Adds to existing law to establish the Medical Advanced Healing Act. (2026 Session)

    1. IntroducedMar 16, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Introduced

    Bill source (opens in a new tab)
  • New Jersey · 7-OH
    Pending
    S301

    7-hydroxymitragynine scheduling (2026–2027)

    1. IntroducedJan 13, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Reported favorably; referred to Senate Budget and Appropriations.

    7-OH Schedule I proposal. No natural-leaf exemption is inferred.

    Bill source (opens in a new tab)
  • Mississippi · Psychedelics
    Enacted
    SB2056

    Controlled substances; provide for automatic scheduling of certain substance if federal scheduling occurs. (2026 Session)

    1. IntroducedJan 8, 2026 (done)
    2. PassedMar 9, 2026 (done)
    3. SignedDate TBC (done)
    4. Law in effectNext step (current)

    · Passed

    Bill source (opens in a new tab)
  • Mississippi · Psychedelics
    Did not pass; died when the session ended
    HB563

    Controlled substances; provide for automatic scheduling of psilocybin after federal scheduling. (2026 Session)

    1. IntroducedJan 13, 2026 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Failed

    Bill source (opens in a new tab)
  • South Dakota · Psychedelics
    Enacted
    HB1099

    An Act to reschedule crystalline polymorph psilocybin in an FDA-approved drug product as a Schedule IV controlled substance (2026 Regular Session)

    Session: January 13, 2026 – March 30, 2026

    1. IntroducedDate TBC (done)
    2. PassedDate TBC (done)
    3. SignedDate TBC (done)
    4. Law in effectNext step (current)

    · Passed

    Bill source (opens in a new tab)
  • Florida · Psychedelics
    Pending
    H0309

    Controlled Substances (2026 Session)

    1. IntroducedNov 4, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Laid on Table, refer to CS/SB 432

    Bill source (opens in a new tab)
  • Minnesota · Psychedelics
    Pending
    SF4204

    Psilocybin regulation provisions (2026 Session)

    1. IntroducedMar 9, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Introduced

    Bill source (opens in a new tab)
  • United States · Psychedelics
    Pending
    SB4031

    Innovative Therapies Centers of Excellence Act (119th Congress)

    Session: January 3, 2025 – January 3, 2027

    1. IntroducedMar 9, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Introduced

    Still pending as of Oct 21, 2026: in Senate Veterans' Affairs since March 9, 2026.

    Bill source (opens in a new tab)
  • Georgia · Psychedelics
    Pending
    HB1296

    Mental health; pilot program to support clinical research of certain veterans and first responders suffering from certain conditions; provide (2026 Session)

    1. IntroducedFeb 12, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred

    Bill source (opens in a new tab)
  • Oregon · Psychedelics
    Did not pass; died when the session ended
    HB4110

    Relating to ibogaine; prescribing an effective date. (2026 Session)

    1. IntroducedFeb 2, 2026 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Failed

    Bill source (opens in a new tab)
  • Utah · Psychedelics
    Did not pass; died when the session ended
    SB0114

    Controlled Substances Amendments (2026 Session)

    1. IntroducedJan 20, 2026 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Failed

    Bill source (opens in a new tab)
  • Rhode Island · Psychedelics
    Pending
    H7925

    Amends current law on controlled substances to permit psilocybin to be cultivated within a person's residence for personal use and contingent on the Food and Drug Administration (FDA) program, mandates that RI DOH establishes rules regulations. (2026 Session)

    1. IntroducedFeb 27, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Introduced

    Bill source (opens in a new tab)
  • Michigan · Psychedelics
    Pending
    SB0802

    Controlled substances: conduct associated with qualified psychoactive substances exempt from criminal penalties in certain circumstances (2025–2026 Regular Session)

    Session: January 8, 2025 – December 31, 2026

    1. IntroducedFeb 26, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Introduced

    Referred to Regulatory Affairs on Feb 26, 2026; later action unconfirmed (low confidence — check).

    Bill source (opens in a new tab)
  • Missouri · Psychedelics
    Pending
    HB1643

    Modifies provisions relating to alternative therapies and treatments, including psilocybin (2026 Session)

    1. IntroducedJan 7, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Committee Report

    Bill source (opens in a new tab)
  • Missouri · Psychedelics
    Pending
    HB2961

    Creates provisions relating to ibogaine treatment (2026 Session)

    1. IntroducedJan 13, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Committee Report

    Bill source (opens in a new tab)
  • Kansas · Psychedelics
    Pending
    HB2218

    Amending the definition of "psilocybin" in the uniform controlled substances act to exclude the pharmaceutical composition of crystalline polymorph psilocybin and adding crystalline polymorph psilocybin to schedule IV of the uniformed controlled substance act. (2026 Session)

    1. IntroducedFeb 3, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · House Stricken from Calendar by Rule 1507

    Bill source (opens in a new tab)
  • New Jersey · Kratom
    Pending
    A4222

    Kratom consumer protection (2026–2027)

    1. IntroducedFeb 19, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred to Assembly Consumer Affairs.

    Kratom consumer-protection regulation proposal; not enacted.

    Bill source (opens in a new tab)
  • Arizona · Psychedelics
    Pending
    SB1542

    Controlled substances; approval; use; research (2026 Session)

    1. IntroducedFeb 2, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Committee Report

    Bill source (opens in a new tab)
  • West Virginia · Psychedelics
    Did not pass; died when the session ended
    HB5588

    Establish a regulated framework for the medical use of psilocybin to treat post-traumatic stress disorder (PTSD) (2026 Session)

    1. IntroducedFeb 16, 2026 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • Maryland · Psychedelics
    Pending
    HB1477

    Public Health - Ibogaine Clinical Research Grant Program - Establishment (Veterans Mental Health Innovations Act) (2026 Session)

    1. IntroducedFeb 13, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Introduced

    Bill source (opens in a new tab)
  • Oklahoma · Psychedelics
    Pending
    HB4293

    Controlled dangerous substances; Veterans Mental Health Innovation Act; authorizing certain scientific research and clinical trials related to ibogaine; requiring registration; providing certain immunities; effective date. (2026 Session)

    1. IntroducedFeb 2, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred

    Bill source (opens in a new tab)
  • Wyoming · Kratom
    Enacted
    SF0056

    Kratom product regulation (2026)

    1. IntroducedFeb 10, 2026 (done)
    2. PassedDate TBC (done)
    3. SignedDate TBC (done)
    4. Law in effectNext step (current)

    · Introduced and referred to Senate Judiciary.

    Enacted as Senate Enrolled Act 44, Chapter 68. Official summary specifies multiple effective dates; signature date and individual commencement dates unconfirmed.

    Bill source (opens in a new tab)
  • Maryland · Psychedelics
    Pending
    SB527

    Public Health - Ibogaine Clinical Research Grant Program - Establishment (Veterans Mental Health Innovations Act) (2026 Session)

    1. IntroducedFeb 4, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Hearing 2/24 at 1:00 p.m.

    Bill source (opens in a new tab)
  • Iowa · Psychedelics
    Pending
    SF2151

    A bill for an act removing psilocybin and psilocyn from the list of substances classified as schedule I controlled substances under Iowa's uniform controlled substances Act. (2026 Session)

    1. IntroducedJan 29, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Subcommittee: Sweeney, Donahue, and Webster. S.J. 214.

    Bill source (opens in a new tab)
  • New Mexico · Psychedelics
    Did not pass; died when the session ended
    HB336

    Use Of Fda-approved Psilocybin (2026 Session)

    1. IntroducedFeb 4, 2026 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • Washington · Psychedelics
    Pending
    SB5921

    Concerning psilocybin. (2026 Session)

    1. IntroducedJan 12, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred

    Bill source (opens in a new tab)
  • Mississippi · Psychedelics
    Did not pass; died when the session ended
    SB2561

    Ibogaine; authorize MSDH to select a consortium to conduct a drug development clinical trial to secure FDA's approval of. (2026 Session)

    1. IntroducedJan 19, 2026 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Failed

    Bill source (opens in a new tab)
  • Mississippi · Psychedelics
    Did not pass; died when the session ended
    SB2562

    Mississippi Veterans PTSD Ibogaine Research Pilot Program; create. (2026 Session)

    1. IntroducedJan 19, 2026 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Failed

    Bill source (opens in a new tab)
  • New Hampshire · Psychedelics
    Did not pass; died when the session ended
    HB1796

    Allowing the use of psilocybin in approved clinical settings to treat qualified medical conditions. (2026 Session)

    1. IntroducedDec 17, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · In Committee

    Bill source (opens in a new tab)
  • Vermont · Psychedelics
    Pending
    H0859

    An act relating to psychedelic therapy and clinical drug development trials (2026 Session)

    1. IntroducedFeb 3, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Introduced

    Bill source (opens in a new tab)
  • California · Psychedelics
    Did not pass; died when the session ended
    SB751

    Veterans and Former First Responders Research Pilot Program. (2026 Session)

    1. IntroducedFeb 21, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Failed

    Bill source (opens in a new tab)
  • United States · Psychedelics
    Pending
    HB7091

    Expanding Veterans’ Access to Emerging Treatments Act (2026 Session)

    1. IntroducedJan 15, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred

    Bill source (opens in a new tab)
  • West Virginia · Psychedelics
    Did not pass; died when the session ended
    HB4640

    Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration (2026 Session)

    1. IntroducedJan 21, 2026 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · On 1st reading, House Calendar

    Bill source (opens in a new tab)
  • Massachusetts · Psychedelics
    Pending
    S1113

    Relative to removing criminal penalties for limited psilocybin possession (2026 Session)

    1. IntroducedFeb 27, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Accompanied a study order, see S2930

    Bill source (opens in a new tab)
  • Massachusetts · Psychedelics
    Pending
    H2506

    Decriminalizing psilocybin as a treatment for PTSD and certain other conditions (2026 Session)

    1. IntroducedFeb 27, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Accompanied a new draft, see H4986

    Bill source (opens in a new tab)
  • Massachusetts · Psychedelics
    Pending
    H2532

    Relative to therapeutic psilocybin treatment centers (2026 Session)

    1. IntroducedFeb 27, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Accompanied a new draft, see H4986

    Bill source (opens in a new tab)
  • Iowa · Psychedelics
    Pending
    HF2085

    A bill for an act relating to the production and administration of psilocybin and providing penalties. (2026 Session)

    1. IntroducedJan 15, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Subcommittee Meeting: 01/26/2026 12:15PM RM 305 (Cancelled).

    Bill source (opens in a new tab)
  • Pennsylvania · Psychedelics
    Pending
    SB1149

    Amending The Controlled Substance, Drug, Device and Cosmetic Act, further providing for authority to control (2025-2026 Regular Session)

    Session: January 7, 2025 – November 30, 2026

    1. IntroducedJan 23, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Introduced

    Still pending as of Oct 21, 2026: in Senate Judiciary since Jan 23, 2026.

    Bill source (opens in a new tab)
  • West Virginia · Psychedelics
    Did not pass; died when the session ended
    HB4721

    Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration (2026 Session)

    1. IntroducedJan 22, 2026 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • New York · Psychedelics
    Pending
    A09583

    Establishes a research grant program to fund clinical trials of ibogaine for the treatment of veterans for post-traumatic stress disorder; creates a fund to provide monies for the research grant program. (2026 Session)

    1. IntroducedJan 21, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Introduced

    Bill source (opens in a new tab)
  • New Jersey · Psychedelics
    Enacted
    S2283

    Establishes Psilocybin Behavioral Health Access and Therapy Pilot Program; appropriates $6 million. (2024-2025 Legislative Session)

    Session: January 9, 2024 – January 13, 2026

    1. IntroducedDate TBC (done)
    2. PassedDate TBC (done)
    3. SignedJan 20, 2026 (done)
    4. Law in effectNext step (current)

    · Signed into Law

    Bill source (opens in a new tab)
  • New Jersey · Kratom
    Pending
    A1203

    CJ’s Law (2026–2027)

    1. IntroducedJan 13, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred to Assembly Judiciary.

    Would criminalize manufacture and distribution under specified circumstances. Not limited to 7-OH.

    Bill source (opens in a new tab)
  • New Jersey · Psychedelics
    Did not pass; died when the session ended
    A1526

    Establishes Psilocybin Behavioral Health Access and Therapy Pilot Program; appropriates $6 million. (2026 Session)

    1. IntroducedJan 13, 2026 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • New Jersey · Kratom
    Pending
    A1617

    CJ’s Law — kratom restrictions (2026–2027)

    1. IntroducedJan 13, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred to Assembly Consumer Affairs.

    Proposal criminalizing manufacture, sale and possession of substances containing kratom. Not only synthetic 7-OH.

    Bill source (opens in a new tab)
  • New Jersey · Kratom
    Pending
    S1384

    Kratom Consumer Protection Act (2026–2027)

    1. IntroducedJan 13, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred to Senate Commerce.

    Kratom product consumer-protection proposal; not enacted.

    Bill source (opens in a new tab)
  • New Jersey · Psychedelics
    Did not pass; died when the session ended
    S3148

    "Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness. (2026 Session)

    1. IntroducedJan 13, 2026 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • New Jersey · Psychedelics
    Did not pass; died when the session ended
    A3852

    Establishes Psilocybin Behavioral Health Access and Therapy Pilot Program; appropriates $6 million. (2026 Session)

    1. IntroducedFeb 22, 2024 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Substituted by S2283 (SCS/2R)

    Bill source (opens in a new tab)
  • Washington · Psychedelics
    Pending
    HB1433

    Concerning access to psychedelic substances. (2026 Session)

    1. IntroducedJan 20, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · By resolution, reintroduced and retained in present status.

    Bill source (opens in a new tab)
  • Washington · Psychedelics
    Pending
    SB5201

    Concerning access to psychedelic substances. (2026 Session)

    1. IntroducedJan 13, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · By resolution, reintroduced and retained in present status.

    Bill source (opens in a new tab)
  • Washington · Psychedelics
    Pending
    SB5204

    Concerning ibogaine-assisted therapy. (2026 Session)

    1. IntroducedJan 13, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · By resolution, reintroduced and retained in present status.

    Bill source (opens in a new tab)
  • New York · Psychedelics
    Pending
    S01801

    Establishes the psilocybin assisted therapy pilot program; provides such program will be offered to veterans and first responders from New York state; establishes a psilocybin assisted therapy pilot program fund. (2026 Session)

    1. IntroducedJan 13, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · PRINT NUMBER 1801A

    Bill source (opens in a new tab)
  • New York · Psychedelics
    Pending
    A03845

    Establishes the psilocybin assisted therapy pilot program; provides such program will be offered to veterans and first responders from New York state; establishes a psilocybin assisted therapy pilot program fund. (2026 Session)

    1. IntroducedJan 30, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · print number 3845a

    Bill source (opens in a new tab)
  • Nebraska · Psychedelics
    Enacted
    LB877

    Designate certain substances as controlled substances under the Uniform Controlled Substances Act (109th Legislature, Second Session (2026))

    Session: January 7, 2026 – April 17, 2026

    1. IntroducedJan 8, 2026 (done)
    2. PassedFeb 27, 2026 (done)
    3. SignedMar 3, 2026 (done)
    4. Law in effectNext step (current)

    · Session start

    Not a reform bill: LB877 adds substances to Nebraska's controlled-substances schedules. It tightens drug restrictions; it does not legalize, decriminalize or expand psychedelic access.

    Bill source (opens in a new tab)
  • New York · Psychedelics
    Pending
    A00628

    Legalizes adult possession and use of certain natural plant or fungus-based hallucinogens; grants certain protections for individuals lawfully using such hallucinogens; removes such hallucinogens from the list of schedule I controlled substances; makes related provisions. (2026 Session)

    1. IntroducedJan 8, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred

    Bill source (opens in a new tab)
  • New York · Psychedelics
    Pending
    A01522

    Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction. (2026 Session)

    1. IntroducedJan 10, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred

    Bill source (opens in a new tab)
  • New York · Psychedelics
    Pending
    A03775

    Relates to medical use of psilocybin; establishes a psilocybin assisted therapy grant program; makes an appropriation therefor. (2026 Session)

    1. IntroducedJan 30, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred

    Bill source (opens in a new tab)
  • New York · Psychedelics
    Pending
    S00495

    Relates to medical use of psilocybin; establishes a psilocybin assisted therapy grant program; makes an appropriation therefor. (2026 Session)

    1. IntroducedJan 8, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred

    Bill source (opens in a new tab)
  • New York · Psychedelics
    Pending
    S04664

    Directs the commissioner of health, in conjunction with the commissioners of mental health and veterans' services, to conduct a study on the use of ibogaine as a treatment for post-traumatic stress disorder, and the increasing rate of PTSD diagnoses in veterans and first responders. (2026 Session)

    1. IntroducedFeb 11, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred

    Bill source (opens in a new tab)
  • Hawaii · Kratom
    Did not pass; died when the session ended
    HB 717

    Hawaii Kratom Consumer Protection Act (2025–2026)

    1. IntroducedJan 21, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Carried over to 2026; session has since ended.

    No passage verified before 2026 regular session ended. Proposed commencement is not an enacted effective date.

    Bill source (opens in a new tab)
  • Pennsylvania · Kratom
    Pending
    HB 2058

    Kratom product regulation (2025–2026)

    1. IntroducedNov 19, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred to House Health.

    Would regulate kratom through the Controlled Substance, Drug, Device and Cosmetic Act.

    Bill source (opens in a new tab)
  • California · Psychedelics
    Enacted
    AB1103

    Controlled substances: research. (2025–2026 Regular Session)

    Session: December 2, 2024 – August 31, 2026

    1. IntroducedFeb 20, 2025 (done)
    2. PassedSep 9, 2025 (done)
    3. SignedOct 10, 2025 (done)
    4. Law in effectNext step (current)

    · Signed into Law

    Bill source (opens in a new tab)
  • Massachusetts · Psychedelics
    Pending
    S1400

    Authorizing a pilot for the use of psychedelics in licensed treatment facilities (2025 Session)

    1. IntroducedFeb 27, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred

    Bill source (opens in a new tab)
  • South Carolina · Kratom
    Enacted
    S. 221

    South Carolina Kratom Consumer Protection Act (2025–2026)

    1. IntroducedJan 15, 2025 (done)
    2. PassedMay 7, 2025 (done)
    3. SignedMay 12, 2025 (done)
    4. Law in effectJul 11, 2025 (done)

    · Act 35 became effective.

    Act 35 signed 12 May 2025; effective 11 July 2025. Enacted, not pending.

    Bill source (opens in a new tab)
  • Michigan · Psychedelics
    Pending
    HB4686

    Crimes: controlled substances; creating, manufacturing, possessing, or using psilocybin or psilocin; allow under certain circumstances. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 7404a. (2025 Session)

    1. IntroducedJun 25, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Introduced

    Bill source (opens in a new tab)
  • Iowa · Psychedelics
    Vetoed
    HF383

    A bill for an act relating to the controlled substance crystalline polymorph psilocybin. (Formerly HF 14.) Vetoed 6-11-25. (2025 Session)

    1. IntroducedFeb 13, 2025 (done)
    2. PassedMay 19, 2025 (done)
    3. VetoedJun 11, 2025 (failed)
    4. SignedDid not happen (skipped)
    5. Law in effectDid not happen (skipped)

    · Vetoed

    Bill source (opens in a new tab)
  • Iowa · Psychedelics
    Enacted
    SF659

    Appropriations act including crystalline polymorph psilocybin provisions (91st General Assembly (2025–2026))

    Session: January 13, 2025 – May 3, 2026

    1. IntroducedMay 14, 2025 (done)
    2. PassedMay 14, 2025 (done)
    3. SignedJun 11, 2025 (done)
    4. Law in effectJul 1, 2025 (done)

    · Passed

    Bill source (opens in a new tab)
  • Texas · Psychedelics
    Enacted
    SB2308

    Relating to the establishment of a consortium to conduct FDA drug development clinical trials with ibogaine (2025 Regular Session (89th Legislature))

    Session: January 14, 2025 – June 2, 2025

    1. IntroducedMar 11, 2025 (done)
    2. PassedJun 1, 2025 (done)
    3. SignedJun 11, 2025 (done)
    4. Law in effectJun 11, 2025 (done)

    · Passed

    Bill source (opens in a new tab)
  • Maine · Psychedelics
    Did not pass; died when the session ended
    LD1034

    An Act to Decriminalize Personal Possession of Therapeutic Amounts of Psilocybin for Adults (2025 Session)

    1. IntroducedMar 12, 2025 (done)
    2. PassedJun 3, 2025 (done)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Failed

    Bill source (opens in a new tab)
  • New Hampshire · Psychedelics
    Did not pass; died when the session ended
    HB528

    Amending the penalties for the possession and use of psilocybin for persons 18 years of age or older. (2025 Session)

    1. IntroducedJan 14, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Pending Motion Committee Amendment # 2025-2167s; 06/05/2025; Senate Calendar 25

    Bill source (opens in a new tab)
  • Nevada · Psychedelics
    Did not pass; died when the session ended
    AB378

    Creates the Alternative Therapy Pilot Program. (BDR 40-820) (2025 Session)

    1. IntroducedMar 10, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Failed

    Bill source (opens in a new tab)
  • Nevada · Psychedelics
    Enacted
    SJR10

    Urges Congress to take certain actions relating to the therapeutic use of certain psychedelic compounds. (2025 Regular Session)

    Session: February 3, 2025 – June 2, 2025

    1. IntroducedFeb 26, 2025 (done)
    2. PassedDate TBC (done)
    3. SignedDate TBC (done)
    4. Law in effectNext step (current)

    · Enrolled (Passed Both Chambers)

    Bill source (opens in a new tab)
  • Connecticut · Psychedelics
    Did not pass; died when the session ended
    HB07065

    An Act Concerning The Decriminalization Of Possession Of Small Amounts Of Psilocybin. (2025 Session)

    1. IntroducedFeb 24, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Committee Report

    Bill source (opens in a new tab)
  • Texas · Psychedelics
    Did not pass; died when the session ended
    HB4014

    Relating to a study on the use of psychedelic therapies in the treatment of certain conditions. (2025 Session)

    1. IntroducedMar 7, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • Missouri · Psychedelics
    Did not pass; died when the session ended
    HB951

    Modifies provisions relating to alternative therapies and treatments, including psilocybin (2025 Session)

    1. IntroducedJan 21, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • Iowa · Psychedelics
    Did not pass; died when the session ended
    SSB1241

    A bill for an act relating to state government and finances, including by making, modifying, limiting, or reducing appropriations, distributions, or transfers, authorizing expenditure of unappropriated moneys in special funds, providing for properly related matters including crystalline polymorph psilocybin and medical residency and fellowship positions, making corrections, and including effective date and retroactive applicability provisions.(See SF 659.) (2025 Session)

    1. IntroducedMay 14, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • Texas · Psychedelics
    Did not pass; died when the session ended
    HB4813

    Relating to the scheduling of certain controlled substances in response to certain actions by the United States Food and Drug Administration with respect to those substances. (2025 Session)

    1. IntroducedMar 13, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • Pennsylvania · Psychedelics
    Pending
    HB1439

    Amending The Controlled Substance, Drug, Device and Cosmetic Act, further providing for authority to control (2025-2026 Regular Session)

    Session: January 7, 2025 – November 30, 2026

    1. IntroducedMay 12, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Introduced

    Still pending as of Oct 21, 2026: in House Health since May 12, 2025.

    Bill source (opens in a new tab)
  • Texas · Psychedelics
    Did not pass; died when the session ended
    HB3717

    Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy. (2025 Session)

    1. IntroducedMar 4, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Laid on the table subject to call

    Bill source (opens in a new tab)
  • United States · Psychedelics
    Pending
    HB2623

    Innovative Therapies Centers of Excellence Act of 2025 (2025 Session)

    1. IntroducedApr 3, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred

    Bill source (opens in a new tab)
  • Missouri · Psychedelics
    Did not pass; died when the session ended
    HB829

    Modifies provisions relating to alternative therapies and treatments, including psilocybin (2025 Session)

    1. IntroducedJan 9, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Dropped from Calendar - Pursuant to House Rules (H)

    Bill source (opens in a new tab)
  • Texas · Psychedelics
    Did not pass; died when the session ended
    SB3005

    Relating to a study on the use of psychedelic therapies in the treatment of certain conditions. (2025 Session)

    1. IntroducedMar 14, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Co-author authorized

    Bill source (opens in a new tab)
  • Iowa · Psychedelics
    Did not pass; died when the session ended
    HF620

    A bill for an act relating to the production of psilocybin and the administration of psilocybin to persons with post-traumatic stress disorder, and providing penalties.(See HF 978.) (2025 Session)

    1. IntroducedFeb 26, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Withdrawn. H.J. 1073.

    Bill source (opens in a new tab)
  • West Virginia · Psychedelics
    Did not pass; died when the session ended
    HB3344

    Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine (2025 Session)

    1. IntroducedMar 13, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Laid over on 3rd reading 4/11/2025

    Bill source (opens in a new tab)
  • New Mexico · Psychedelics
    Enacted
    SB219

    Medical Psilocybin Act (2025 Regular Session)

    Session: January 21, 2025 – March 22, 2025

    1. IntroducedDate TBC (done)
    2. PassedMar 18, 2025 (done)
    3. SignedApr 7, 2025 (done)
    4. Law in effectNext step (current)

    · Signed into Law

    Bill source (opens in a new tab)
  • Virginia · Psychedelics
    Vetoed
    SB1135

    Crystalline polymorph psilocybin; regulations for prescribing, etc. (2025 Session)

    1. IntroducedJan 7, 2025 (done)
    2. PassedFeb 20, 2025 (done)
    3. VetoedMar 24, 2025 (failed)
    4. SignedDid not happen (skipped)
    5. Law in effectDid not happen (skipped)

    · Senate sustained Governor's veto

    Bill source (opens in a new tab)
  • Colorado · Psychedelics
    Enacted
    HB1063

    FDA-Approved Crystalline Polymorph Psilocybin Use (2025 Session)

    1. IntroducedJan 8, 2025 (done)
    2. PassedMar 26, 2025 (done)
    3. SignedDate TBC (done)
    4. Law in effectNext step (current)

    · Passed

    Bill source (opens in a new tab)
  • North Dakota · Psychedelics
    Enacted
    SB2064

    Relating to the scheduling of controlled substances (2025 Regular Session)

    Session: January 7, 2025 – May 3, 2025

    1. IntroducedJan 7, 2025 (done)
    2. PassedMar 19, 2025 (done)
    3. SignedDate TBC (done)
    4. Law in effectNext step (current)

    · Filed with Secretary Of State 03/26

    Enacted; filed with the Secretary of State on March 26, 2025.

    Bill source (opens in a new tab)
  • West Virginia · Psychedelics
    Did not pass; died when the session ended
    HB3343

    Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration (2025 Session)

    1. IntroducedMar 13, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • North Carolina · Psychedelics
    Did not pass; died when the session ended
    S568

    Innovative Treatments for Mental Health Act (2025 Session)

    1. IntroducedMar 25, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • Minnesota · Psychedelics
    Did not pass; died when the session ended
    HF2699

    Psilocybin cultivation, possession, transportation, and personal use by individuals 21 years of age or older authorized; protections established; public education and harm reduction programs established; Psychedelic Medicine Board established; criminal penalties provided; rulemaking authorized; civil actions authorized; and money appropriated. (2025 Session)

    1. IntroducedMar 24, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • Illinois · Kratom
    Pending
    HB3215

    Illinois Kratom Consumer Protection Act (2025–2026)

    1. IntroducedFeb 18, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Rule 19(a): re-referred to Rules Committee.

    Filed 6 February; formal introduction 18 February 2025. Stalled in Rules Committee, but no terminal disposition verified in the ongoing 104th General Assembly.

    Bill source (opens in a new tab)
  • New Mexico · Psychedelics
    Did not pass; died when the session ended
    HM58

    Study Psilocybin-based Medication Treatment (2025 Session)

    1. IntroducedMar 14, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • Missouri · Psychedelics
    Did not pass; died when the session ended
    SB90

    Modifies provisions relating to alternative therapies and treatments, including psilocybin (2025 Session)

    1. IntroducedJan 8, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · SCS Voted Do Pass S Families, Seniors and Health Committee (1343S.02C)

    Bill source (opens in a new tab)
  • Vermont · Psychedelics
    Did not pass; died when the session ended
    S0106

    An act relating to continuing the Psychedelic Therapy Advisory Working Group (2025 Session)

    1. IntroducedMar 11, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • Vermont · Psychedelics
    Did not pass; died when the session ended
    H0452

    An act relating to decriminalization of psilocybin-containing mushrooms and the establishment of the Psilocybin Therapeutic Consultation Program (2025 Session)

    1. IntroducedFeb 28, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • Iowa · Psychedelics
    Did not pass; died when the session ended
    HF609

    A bill for an act relating to the use of certain psychoactive substances under the religious freedom restoration Act. (2025 Session)

    1. IntroducedFeb 26, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • Nebraska · Psychedelics
    Enacted
    LB72

    Change provisions relating to controlled substances schedules under the Uniform Controlled Substances Act (2025 Session)

    1. IntroducedJan 9, 2025 (done)
    2. PassedFeb 7, 2025 (done)
    3. SignedDate TBC (done)
    4. Law in effectNext step (current)

    · Passed

    Bill source (opens in a new tab)
  • Iowa · Psychedelics
    Did not pass; died when the session ended
    HF14

    A bill for an act relating to the controlled substance crystalline polymorph psilocybin.(See HF 383.) (2025 Session)

    1. IntroducedJan 14, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Withdrawn. H.J. 418.

    Bill source (opens in a new tab)
  • Iowa · Psychedelics
    Did not pass; died when the session ended
    SSB1177

    A bill for an act relating to the controlled substance crystalline polymorph psilocybin. (2025 Session)

    1. IntroducedFeb 24, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • Kentucky · Psychedelics
    Did not pass; died when the session ended
    SB240

    AN ACT relating to Ibogaine research in the Commonwealth. (2025 Session)

    1. IntroducedFeb 18, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • New Mexico · Psychedelics
    Did not pass; died when the session ended
    SB410

    Crystalline Polymorph Psilocybin Rescheduling (2025 Session)

    1. IntroducedFeb 14, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Tabled Indefinitely, Bill Has Died

    Bill source (opens in a new tab)
  • Iowa · Psychedelics
    Did not pass; died when the session ended
    HF351

    A bill for an act removing psilocybin and psilocyn from the list of substances classified as schedule I controlled substances under Iowa's uniform controlled substances Act. (2025 Session)

    1. IntroducedFeb 12, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • Rhode Island · Psychedelics
    Did not pass; died when the session ended
    H5186

    Amends current law on controlled substances to permit psilocybin to be cultivated within a person's residence for personal use and contingent on the US FDA's program, mandate that RI department of health establish rules regulations. (2025 Session)

    1. IntroducedJan 24, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Committee recommended measure be held for further study

    Bill source (opens in a new tab)
  • Pennsylvania · Kratom
    Pending
    SB 233

    Kratom Consumer Protection Act (2025–2026)

    1. IntroducedFeb 4, 2025 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred to Health and Human Services.

    Unsafe-product restrictions and minimum purchase age 21; not enacted.

    Bill source (opens in a new tab)
  • Connecticut · Psychedelics
    Did not pass; died when the session ended
    HB06380

    An Act Decriminalizing The Possession Of Psilocybin. (2025 Session)

    1. IntroducedJan 23, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • Connecticut · Psychedelics
    Did not pass; died when the session ended
    SB00855

    An Act Concerning Funding For The Psychedelic-assisted Therapy Pilot Program. (2025 Session)

    1. IntroducedJan 22, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • Connecticut · Psychedelics
    Did not pass; died when the session ended
    HB05456

    An Act Allowing The Use Of Psilocybin For Medicinal And Therapeutic Purposes. (2025 Session)

    1. IntroducedJan 17, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • Illinois · Psychedelics
    Did not pass; died when the session ended
    SB2353

    CONTROLLED SUB-PSILOCYBIN (2025 Session)

    1. IntroducedFeb 10, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Failed

    Bill source (opens in a new tab)
  • Michigan · Psychedelics
    Did not pass; died when the session ended
    HB5980

    Crimes: controlled substances; creating, manufacturing, possessing, or using psilocybin or psilocin; allow under certain circumstances. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 7404a. (2024 Session)

    1. IntroducedSep 26, 2024 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Bill Electronically Reproduced 10/15/2024

    Bill source (opens in a new tab)
  • New Hampshire · Psychedelics
    Did not pass; died when the session ended
    HB1693

    Relative to the use of psychedelics for therapeutic purposes. (2024 Session)

    1. IntroducedDec 15, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Executive Session: 10/09/2024 01:00 pm Legislative Office Building 205-207

    Bill source (opens in a new tab)
  • United States · Psychedelics
    Did not pass; died when the session ended
    HB7347

    To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to report on whether the Secretary will include certain psychedelic drugs in the formulary of the Department of Veterans Affairs. (2024 Session)

    1. IntroducedFeb 14, 2024 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Placed on the Union Calendar, Calendar No. 544.

    Bill source (opens in a new tab)
  • Massachusetts · Psychedelics
    Did not pass; died when the session ended
    H1754

    Relative to plant medicine (2024 Session)

    1. IntroducedFeb 16, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Accompanied a study order, see H5032

    Bill source (opens in a new tab)
  • Massachusetts · Psychedelics
    Did not pass; died when the session ended
    H3605

    Concerning the legal use of the plant medicine known as psilocybin for therapeutic, spiritual, and medicinal purposes (2024 Session)

    1. IntroducedMar 30, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Accompanied a study order, see H5018

    Bill source (opens in a new tab)
  • Massachusetts · Psychedelics
    Did not pass; died when the session ended
    S1009

    Relative to plant medicine (2024 Session)

    1. IntroducedFeb 16, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Accompanied a study order, see S2926

    Bill source (opens in a new tab)
  • California · Psychedelics
    Did not pass; died when the session ended
    AB941

    Controlled substances: psychedelic-assisted therapy. (2024 Session)

    1. IntroducedFeb 14, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · In committee: Set, first hearing. Hearing canceled at the request of author.

    Bill source (opens in a new tab)
  • Massachusetts · Psychedelics
    Did not pass; died when the session ended
    H3574

    Concerning the use of a prescription medicine that contains 3,4-methylenedioxymethamphetamine (MDMA) (2024 Session)

    1. IntroducedMar 30, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Accompanied a study order, see H4739

    Bill source (opens in a new tab)
  • New York · Psychedelics
    Did not pass; died when the session ended
    A10375

    Allows the growth, cultivation, and regulated adult use of psilocybin for the treatment of certain health conditions; provides for the certification of support service providers and the licensure of cultivators. (2024 Session)

    1. IntroducedMay 21, 2024 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • Missouri · Psychedelics
    Did not pass; died when the session ended
    SB768

    Modifies provisions relating to alternative therapies and treatments, including psilocybin (2024 Session)

    1. IntroducedJan 3, 2024 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Formal Calendar S Bills for Perfection

    Bill source (opens in a new tab)
  • California · Psychedelics
    Did not pass; died when the session ended
    SB1012

    The Regulated Psychedelic Facilitators Act and the Regulated Psychedelic-Assisted Therapy Act. (2024 Session)

    1. IntroducedFeb 5, 2024 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · May 16 hearing: Held in committee and under submission.

    Bill source (opens in a new tab)
  • Maryland · Psychedelics
    Enacted
    HB548

    Task Force on Responsible Use of Natural Psychedelic Substances (2024 Session)

    1. IntroducedJan 24, 2024 (done)
    2. PassedApr 4, 2024 (done)
    3. SignedMay 16, 2024 (done)
    4. Law in effectNext step (current)

    · Signed into Law

    Bill source (opens in a new tab)
  • Maryland · Psychedelics
    Enacted
    SB1009

    Task Force on Responsible Use of Natural Psychedelic Substances (2024 Session)

    1. IntroducedFeb 2, 2024 (done)
    2. PassedApr 3, 2024 (done)
    3. SignedMay 16, 2024 (done)
    4. Law in effectNext step (current)

    · Signed into Law

    Bill source (opens in a new tab)
  • Maine · Psychedelics
    Did not pass; died when the session ended
    LD1914

    Resolve, to Establish the Commission to Study Pathways for Creating a Psilocybin Services Program in Maine (2024 Session)

    1. IntroducedMay 9, 2023 (done)
    2. PassedApr 3, 2024 (done)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · CARRIED OVER, in the same posture, to any special session of the 131st Legislature, pursuant to Joint Order HP 1482.

    Bill source (opens in a new tab)
  • Vermont · Psychedelics
    Enacted
    S0114

    An act relating to the establishment of the Psychedelic Therapy Advisory Working Group (2024 Session)

    1. IntroducedMar 1, 2023 (done)
    2. PassedMay 10, 2024 (done)
    3. SignedDate TBC (done)
    4. Law in effectNext step (current)

    · Enrolled (Passed Both Chambers)

    Bill source (opens in a new tab)
  • Massachusetts · Psychedelics
    Did not pass; died when the session ended
    H4255

    Relative to the regulation and taxation of natural psychedelic substances (2024 Session)

    1. IntroducedFeb 1, 2024 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · In Committee

    Bill source (opens in a new tab)
  • Massachusetts · Psychedelics
    Did not pass; died when the session ended
    H4607

    REPORT of the SPECIAL JOINT COMMITTEE on INITIATIVE PETITIONS on the INITIATIVE PETITION of SARKO GERGERIAN AND OTHERS FOR THE PASSAGE OF AN ACT RELATIVE TO THE REGULATION AND TAXATION OF NATURAL PSYCHEDELIC SUBSTANCES (see House, No. 4255) (2024 Session)

    1. IntroducedMay 2, 2024 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • Connecticut · Psychedelics
    Did not pass; died when the session ended
    HB05297

    An Act Concerning The Decriminalization Of Possession Of Small Amounts Of Psilocybin. (2024 Session)

    1. IntroducedFeb 26, 2024 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • New York · Psychedelics
    Did not pass; died when the session ended
    S08807

    Directs the commissioner of health, in conjunction with the commissioners of mental health and veterans' services, to conduct a study on the use of ibogaine as a treatment for post-traumatic stress disorder, and the increasing rate of PTSD diagnoses in veterans and first responders. (2024 Session)

    1. IntroducedMar 14, 2024 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • New Mexico · Psychedelics
    Enacted
    SM12

    Study Psilocybin For Therapeutic Treatments (2024 Session)

    1. IntroducedFeb 6, 2024 (done)
    2. PassedDate TBC (done)
    3. SignedDate TBC (done)
    4. Law in effectNext step (current)

    · Engrossed (Passed One Chamber)

    Bill source (opens in a new tab)
  • Massachusetts · Psychedelics
    Did not pass; died when the session ended
    S1263

    Regulating the safe use of psilocybin (2024 Session)

    1. IntroducedFeb 16, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Accompanied a study order, see S2642

    Bill source (opens in a new tab)
  • New York · Psychedelics
    Did not pass; died when the session ended
    S07832

    Establishes the psilocybin assisted therapy pilot program; provides such program will be offered to ten thousand veterans and first responders from the western region of New York state. (2024 Session)

    1. IntroducedDec 20, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · PRINT NUMBER 7832A

    Bill source (opens in a new tab)
  • Rhode Island · Psychedelics
    Did not pass; died when the session ended
    H7047

    Amends the current law on controlled substances to permit a person to be in possession of less than one ounce of psilocybin and permits psilocybin to be securely cultivated within a person's residence for personal use. (2024 Session)

    1. IntroducedJan 5, 2024 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Committee recommended measure be held for further study

    Bill source (opens in a new tab)
  • New York · Psychedelics
    Did not pass; died when the session ended
    A08349

    Establishes the psilocybin assisted therapy pilot program; provides such program will be offered to ten thousand veterans and first responders from the western region of New York state. (2024 Session)

    1. IntroducedDec 13, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · print number 8349a

    Bill source (opens in a new tab)
  • Washington · Psychedelics
    Did not pass; died when the session ended
    HB2281

    Concerning psilocybin services. (2024 Session)

    1. IntroducedJan 10, 2024 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • Washington · Psychedelics
    Did not pass; died when the session ended
    SB5977

    Concerning psilocybin services. (2024 Session)

    1. IntroducedJan 8, 2024 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • New York · Psychedelics
    Did not pass; died when the session ended
    A03581

    Relates to medical use of psilocybin; establishes a psilocybin assisted therapy grant program; makes an appropriation therefor. (2024 Session)

    1. IntroducedFeb 3, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • New York · Psychedelics
    Did not pass; died when the session ended
    A06210

    Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction. (2024 Session)

    1. IntroducedApr 3, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • New York · Psychedelics
    Did not pass; died when the session ended
    S03520

    Relates to medical use of psilocybin; establishes a psilocybin assisted therapy grant program; makes an appropriation therefor. (2024 Session)

    1. IntroducedJan 31, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • New York · Psychedelics
    Did not pass; died when the session ended
    S06180

    Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction. (2024 Session)

    1. IntroducedApr 3, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • Hawaii · Psychedelics
    Did not pass; died when the session ended
    HB1337

    Relating To Psilocybin. (2023 Session)

    1. IntroducedJan 25, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Carried over to 2024 Regular Session.

    Bill source (opens in a new tab)
  • Hawaii · Psychedelics
    Did not pass; died when the session ended
    SB1454

    Relating To Psilocybin. (2023 Session)

    1. IntroducedJan 25, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Carried over to 2024 Regular Session.

    Bill source (opens in a new tab)
  • Michigan · Psychedelics
    Did not pass; died when the session ended
    SB0499

    Controlled substances: penalties; conduct associated with entheogenic plants and fungi; exempt from criminal penalties in certain circumstances. Amends secs. 7401, 7403 & 7404 of 1978 PA 368 (MCL 333.7401 et seq.). (2023 Session)

    1. IntroducedSep 14, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • Washington · Psychedelics
    Enacted
    SB5263

    Concerning access to psilocybin services by individuals 21 years of age and older. (2023 Session)

    1. IntroducedJan 11, 2023 (done)
    2. PassedApr 20, 2023 (done)
    3. SignedMay 9, 2023 (done)
    4. Law in effectNext step (current)

    · Effective date 7/23/2023*.

    Bill source (opens in a new tab)
  • United States · Psychedelics
    Pending
    HB4242

    To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy. (2023 Session)

    1. IntroducedJun 21, 2023 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Referred

    Bill source (opens in a new tab)
  • United States · Psychedelics
    Pending
    HB3684

    Douglas Mike Day Psychedelic Therapy to Save Lives Act of 2023 (2023 Session)

    1. IntroducedMay 25, 2023 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Introduced

    Bill source (opens in a new tab)
  • Connecticut · Psychedelics
    Did not pass; died when the session ended
    HB06734

    An Act Concerning The Decriminalization Of Possession Of Small Amounts Of Psilocybin. (2023 Session)

    1. IntroducedFeb 22, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Committee Report

    Bill source (opens in a new tab)
  • Iowa · Psychedelics
    Did not pass; died when the session ended
    HF240

    A bill for an act removing psilocybin and psilocyn from the list of substances classified as schedule I controlled substances under Iowa's uniform controlled substances Act. (2023 Session)

    1. IntroducedFeb 8, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Subcommittee recommends passage. Vote Total: 3-0.

    Bill source (opens in a new tab)
  • Oklahoma · Psychedelics
    Did not pass; died when the session ended
    HB2107

    Controlled dangerous substances; authorizing certain scientific research and clinical trials related to psilocybin and psilocyn; requiring registration; providing certain immunities; effective date. (2023 Session)

    1. IntroducedFeb 6, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • Texas · Psychedelics
    Did not pass; died when the session ended
    HB4423

    Relating to the establishment of the Psilocybin Research Advisory Council. (2023 Session)

    1. IntroducedMar 9, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • Hawaii · Psychedelics
    Did not pass; died when the session ended
    HCR202

    Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group. (2023 Session)

    1. IntroducedMar 10, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • Hawaii · Psychedelics
    Did not pass; died when the session ended
    HR206

    Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group. (2023 Session)

    1. IntroducedMar 10, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • Hawaii · Psychedelics
    Did not pass; died when the session ended
    SCR133

    Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group. (2023 Session)

    1. IntroducedMar 10, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • Hawaii · Psychedelics
    Did not pass; died when the session ended
    SCR215

    Requesting The Department Of Health To Convene A Medicinal Psychedelics Right-to-try Task Force To Explore The Development Of A Program For Qualifying Terminally Ill Patients. (2023 Session)

    1. IntroducedMar 10, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • Hawaii · Psychedelics
    Did not pass; died when the session ended
    SR153

    Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group. (2023 Session)

    1. IntroducedMar 10, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • Hawaii · Psychedelics
    Did not pass; died when the session ended
    SR206

    Requesting The Department Of Health To Convene A Medicinal Psychedelics Right-to-try Task Force To Explore The Development Of A Program For Qualifying Terminally Ill Patients. (2023 Session)

    1. IntroducedMar 10, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • Minnesota · Psychedelics
    Enacted
    HF1884

    Psychedelic medicine task force established, and report required. (2023 Session)

    1. IntroducedFeb 16, 2023 (done)
    2. PassedDate TBC (done)
    3. SignedDate TBC (done)
    4. Law in effectNext step (current)

    · Author added Hudson

    Bill source (opens in a new tab)
  • New Hampshire · Psychedelics
    Did not pass; died when the session ended
    HB216

    Exempting dimethyltryptamine from the controlled drug act. (2023 Session)

    1. IntroducedJan 3, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Inexpedient to Legislate: Motion Adopted DV 274-97 03/09/2023 House Journal 8 P. 27

    Bill source (opens in a new tab)
  • Minnesota · Psychedelics
    Did not pass; died when the session ended
    SF1954

    Psychedelic medicine task force establishment (2023 Session)

    1. IntroducedFeb 20, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Author added Kupec

    Bill source (opens in a new tab)
  • Utah · Psychedelics
    Did not pass; died when the session ended
    SB0200

    Psilocybin Recommendation Pilot Program Amendments (2023 Session)

    1. IntroducedFeb 10, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Failed

    Bill source (opens in a new tab)
  • New Mexico · Psychedelics
    Did not pass; died when the session ended
    HB393

    Study Use Of Psilocybin For Mental Health (2023 Session)

    1. IntroducedFeb 13, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Committee Report

    Bill source (opens in a new tab)
  • Vermont · Psychedelics
    Did not pass; died when the session ended
    H0439

    An act relating to decriminalizing certain chemical compounds found in plants and fungi that are commonly used for medicinal, spiritual, religious, or entheogenic purposes (2023 Session)

    1. IntroducedMar 1, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • Vermont · Psychedelics
    Did not pass; died when the session ended
    H0371

    An act relating to removal of criminal penalties for possessing, dispensing, or selling psilocybin and establishment of the Psychedelic Therapy Advisory Working Group (2023 Session)

    1. IntroducedFeb 24, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • Virginia · Psychedelics
    Did not pass; died when the session ended
    SB932

    Virginia Psilocybin Advisory Board; established, report. (2023 Session)

    1. IntroducedJan 6, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Tabled in Rules (13-Y 5-N)

    Bill source (opens in a new tab)
  • Connecticut · Psychedelics
    Did not pass; died when the session ended
    HB06146

    An Act Concerning The Psychedelic-assisted Therapy Pilot Program. (2023 Session)

    1. IntroducedJan 18, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Change of Reference, Senate to Committee on Appropriations

    Bill source (opens in a new tab)
  • Virginia · Psychedelics
    Did not pass; died when the session ended
    HB1513

    Psilocybin; possession or distribution for certain medical purposes permitted, penalty. (2023 Session)

    1. IntroducedJan 4, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Left in Courts of Justice

    Bill source (opens in a new tab)
  • Hawaii · Psychedelics
    Did not pass; died when the session ended
    SCR5

    Requesting The Department Of Health To Convene A Medicinal Psilocybin And Psilocin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Psilocin And Develop A Long-term Strategic Plan To Ensure The Availability Of Medicinal Psilocybin And Psilocin Or Psilocybin-based And Psilocin-based Products That Are Safe, Accessible, And Affordable For Eligible Adult Patients. (2023 Session)

    1. IntroducedJan 25, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • Hawaii · Psychedelics
    Did not pass; died when the session ended
    SR3

    Requesting The Department Of Health To Convene A Medicinal Psilocybin And Psilocin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Psilocin And Develop A Long-term Strategic Plan To Ensure The Availability Of Medicinal Psilocybin And Psilocin Or Psilocybin-based And Psilocin-based Products That Are Safe, Accessible, And Affordable For Eligible Adult Patients. (2023 Session)

    1. IntroducedJan 25, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • Connecticut · Psychedelics
    Did not pass; died when the session ended
    HB05102

    An Act Allowing The Use Of Psilocybin For Medicinal And Therapeutic Purposes. (2023 Session)

    1. IntroducedJan 9, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • New Jersey · Psychedelics
    Did not pass; died when the session ended
    A4911

    "Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness; decriminalizes, and expunges past offenses involving, psilocybin production, possession, use, and distribution. (2022 Session)

    1. IntroducedDec 5, 2022 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • New Jersey · Psychedelics
    Did not pass; died when the session ended
    S2934

    "Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness; decriminalizes, and expunges past offenses involving, psilocybin production, possession, use, and distribution. (2022 Session)

    1. IntroducedJun 23, 2022 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Introduced

    Bill source (opens in a new tab)
  • Colorado · Psychedelics
    Enacted
    HB1344

    FDA-approved Prescription 3,4-Methylenedioxymethamphetamine Drug Use (2022 Session)

    1. IntroducedMar 28, 2022 (done)
    2. PassedMay 31, 2022 (done)
    3. SignedDate TBC (done)
    4. Law in effectNext step (current)

    · Passed

    Bill source (opens in a new tab)
  • Hawaii · Psychedelics
    Pending
    SR88

    Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Develop A Longterm Strategic Plan, Should Food And Drug Administration Approval For Medical Use Be Obtained, To Enable The Availability Of Therapeutic Psilocybin Or Psilocybin-based Products That Are Safe, Accessible, And Affordable For Adults Twenty-one Years Of Age Or Older. (2022 Session)

    1. IntroducedMar 11, 2022 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Certified copies of resolutions sent, 06/06/22.

    Bill source (opens in a new tab)
  • Hawaii · Psychedelics
    Did not pass; died when the session ended
    SCR100

    Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Develop A Long-term Strategic Plan, Should Food And Drug Administration Approval For Medical Use Be Obtained, To Enable The Availability Of Therapeutic Psilocybin Or Psilocybin-based Products That Are Safe, Accessible, And Affordable For Adults Twenty-one Years Of Age Or Older. (2022 Session)

    1. IntroducedMar 11, 2022 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Committee Report

    Bill source (opens in a new tab)
  • Oklahoma · Psychedelics
    Did not pass; died when the session ended
    HB3414

    Controlled dangerous substances; authorizing certain research and clinical trials related to psilocybin and psilocin; requiring registration; providing certain immunities. (2022 Session)

    1. IntroducedFeb 7, 2022 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Coauthored by Representative Pae

    Bill source (opens in a new tab)
  • New Hampshire · Psychedelics
    Did not pass; died when the session ended
    HB1349

    Decriminalizing the possession and use of psilocybin mushrooms. (2022 Session)

    1. IntroducedNov 20, 2021 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Lay HB1349 on Table (Rep. Abbas): Motion Adopted Regular Calendar 210-132 03/31/2022 House Journal 9

    Bill source (opens in a new tab)
  • Hawaii · Psychedelics
    Did not pass; died when the session ended
    SCR227

    Requesting The Department Of Health To Convene A Medicinal Psilocybin And Psilocin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Psilocin And Develop A Long-term Strategic Plan To Ensure The Availability Of Medicinal Psilocybin And Psilocin Or Psilocybin-based And Psilocin-based Products That Are Safe, Accessible, And Affordable For Eligible Adult Patients. (2022 Session)

    1. IntroducedMar 11, 2022 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • Hawaii · Psychedelics
    Did not pass; died when the session ended
    SB3160

    Relating To Psilocybin. (2022 Session)

    1. IntroducedJan 26, 2022 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • Oklahoma · Psychedelics
    Did not pass; died when the session ended
    HB3174

    Public health; providing for the establishment of statewide investigational new drug applications for psilocybin clinical trials; effective date. (2022 Session)

    1. IntroducedFeb 7, 2022 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • Virginia · Psychedelics
    Did not pass; died when the session ended
    SB262

    Psilocybin or psilocyn; possession, civil penalty. (2022 Session)

    1. IntroducedJan 11, 2022 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Passed by indefinitely in Judiciary (8-Y 6-N 1-A)

    Bill source (opens in a new tab)
  • Hawaii · Psychedelics
    Did not pass; died when the session ended
    HB2400

    Relating To Psilocybin. (2022 Session)

    1. IntroducedJan 26, 2022 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    · Referred

    Bill source (opens in a new tab)
  • Arizona · Psychedelics
    Did not pass; died when the session ended
    HB2105

    psilocybin research (2024 Fifty-sixth Legislature 2nd Regular)

    1. IntroducedDate TBC (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    No dated action recorded

    Bill source (opens in a new tab)
  • Arizona · Psychedelics
    Vetoed
    SB1570

    psilocybin services; regulation; licensure (2024 Fifty-sixth Legislature 2nd Regular)

    1. IntroducedDate TBC (done)
    2. PassedDate TBC (done)
    3. VetoedJun 18, 2024 (failed)
    4. SignedDid not happen (skipped)
    5. Law in effectDid not happen (skipped)

    No dated action recorded

    Bill source (opens in a new tab)
  • Arkansas · Kratom
    Did not pass; died when the session ended
    SB 534

    Arkansas Kratom Consumer Protection Act (2025)

    1. IntroducedMar 20, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    No dated action recorded

    Kratom / 7-OH bill, not a psychedelics bill. Proposed KCPA and removal of mitragynine and 7-OH from controlled list; not enacted.

    Bill source (opens in a new tab)
  • Colorado · Kratom
    Enacted
    SB 25-072

    Regulation of Kratom (2025)

    1. IntroducedDate TBC (done)
    2. PassedDate TBC (done)
    3. SignedDate TBC (done)
    4. Law in effectNext step (current)

    No dated action recorded

    Kratom / 7-OH bill, not a psychedelics bill.

    Bill source (opens in a new tab)
  • Florida · Psychedelics
    Did not pass; died when the session ended
    HB549

    Use of Psilocybin for Mental Health Treatment (2021 Regular Session)

    1. IntroducedJan 28, 2021 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    No dated action recorded

    Bill source (opens in a new tab)
  • Hawaii · Kratom
    Current status not confirmed
    SB 463

    Hawaii Kratom Consumer Protection Act (2025–2026)

    1. IntroducedDate TBC (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    No dated action recorded

    2026 session ended; primary bill history blocked. Old carryover does not establish current pendency.

    Bill source (opens in a new tab)
  • Idaho · Kratom
    Did not pass; died when the session ended
    SB 1418

    Idaho Kratom Consumer Protection and Safety Act (2026)

    1. IntroducedDate TBC (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    No dated action recorded

    Kratom / 7-OH bill, not a psychedelics bill.

    Bill source (opens in a new tab)
  • Michigan · Kratom
    Current status not confirmed
    HB5537

    Prohibit conduct related to kratom (2025–2026)

    1. IntroducedDate TBC (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    No dated action recorded

    Official analysis includes kratom leaf, not just synthetic 7-OH. House passage confirmed 18 March 2026; final Senate action date/current status needs confirmation.

    Bill source (opens in a new tab)
  • Mississippi · Kratom
    Current status not confirmed
    HB 1077

    Kratom product standards (2025)

    1. IntroducedDate TBC (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    No dated action recorded

    Reported governor approval 17 April 2025 awaits primary-history confirmation. Not counted as pending; signature and effective dates unconfirmed.

    Bill source (opens in a new tab)
  • Montana · Psychedelics
    Did not pass; died when the session ended
    HB955

    Legalize psilocybin use for PTSD/mental illness treatment (2023 Regular Session)

    1. IntroducedMar 27, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    No dated action recorded

    Bill source (opens in a new tab)
  • New York · Kratom
    Pending
    S8136

    Enacts the New York State Kratom Consumer Protection Act (2025)

    1. IntroducedDate TBC (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    No dated action recorded

    Kratom / 7-OH bill, not a psychedelics bill.

    Bill source (opens in a new tab)
  • Ohio · Kratom
    Did not pass; died when the session ended
    SB 103

    Regulate kratom and hemp-derived products (135th General Assembly)

    1. IntroducedDate TBC (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    No dated action recorded

    Kratom / 7-OH bill, not a psychedelics bill. Proposed kratom-sales regulation; no enacted statewide framework identified.

    Bill source (opens in a new tab)
  • Oregon · Psychedelics
    Enacted
    HB2387

    Relating to psilocybin (2025 Regular Session)

    1. IntroducedDate TBC (done)
    2. PassedDate TBC (done)
    3. SignedDate TBC (done)
    4. Law in effectNext step (current)

    No dated action recorded

    Bill source (opens in a new tab)
  • Oregon · Psychedelics
    Enacted
    SB844

    Relating to public health (2025 Regular Session)

    1. IntroducedDate TBC (done)
    2. PassedJun 27, 2025 (done)
    3. SignedDate TBC (done)
    4. Law in effectNext step (current)

    No dated action recorded

    Bill source (opens in a new tab)
  • Pennsylvania · Psychedelics
    Did not pass; died when the session ended
    HB1959

    Psilocybin research and clinical studies (2021-2022 Regular Session)

    1. IntroducedOct 12, 2021 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    No dated action recorded

    Bill source (opens in a new tab)
  • Pennsylvania · Psychedelics
    Did not pass; died when the session ended
    HB2421

    Psilocybin and psilocybin-assisted therapy research (2021-2022 Regular Session)

    1. IntroducedMar 16, 2022 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    No dated action recorded

    Bill source (opens in a new tab)
  • Wisconsin · Psychedelics
    Did not pass; died when the session ended
    AB753

    Medicinal psilocybin treatment fund and PTSD pilot program (2023-2024 Regular Session)

    1. IntroducedDec 6, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    No dated action recorded

    Bill source (opens in a new tab)
  • Wisconsin · Psychedelics
    Did not pass; died when the session ended
    SB727

    Medicinal psilocybin treatment fund and PTSD pilot program (2023-2024 Regular Session)

    1. IntroducedNov 21, 2023 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    No dated action recorded

    Bill source (opens in a new tab)